Who Are General Partners in VC?: Roles, Risks, and Realities

Header image: Nordhaus, Raines, adjutants general visit National Guard Baltic partners (9734229).jpg) by U.S. Army National Guard photo by Master Sgt. Zach Sheely, Public domain, via Wikimedia Commons — cropped to 16:9 and colour-adjusted.

General partners in venture capital sign the checks. They also sign the legal documents that put their personal assets on the line if the fund implodes. They make the final call on deals, shape the fund’s terms, and answer to institutional investors when returns disappoint. Unlike limited partners, who write checks and step back, or venture partners, who advise but don’t vote, GPs say “yes” or “no” to every investment. They structure the fund’s economics. They carry unlimited liability. If VC firms feel like black boxes, it’s because GPs control the capital, the narrative, and the risk.

That’s the straightforward answer. The reality is messier. The GP title carries weight, but it also comes with power imbalances, deal attribution battles, and relentless pressure to deliver returns—not excuses—to pension funds and insurers.

---

The Legal and Financial Stakes: Why Unlimited Liability Isn’t Just Fine Print

Most founders—and even some junior VCs—miss this: GPs are personally on the hook for the fund’s debts and legal troubles. If a portfolio company gets sued for IP infringement and the fund’s insurance doesn’t cover it, the GP’s personal assets could be at risk. This isn’t hypothetical. It’s baked into the legal structure of every VC fund.

Limited partners—pension funds, endowments, insurers—love this setup. Their liability is capped at their investment. If the fund loses money, they lose only what they put in. GPs, by contrast, face unlimited liability. That’s why you’ll rarely see a GP without deep pockets, a robust legal team, or both.

This asymmetry shapes everything. It influences how GPs structure deals, favoring safer terms like liquidation preferences. It affects how they report to LPs—transparency has limits when personal risk is involved. It even dictates how they exit investments—a quick sale might look better than a high-risk, high-reward IPO. The legal exposure isn’t a footnote. It’s the foundation of the GP’s decision-making.

---

The GP’s Day-to-Day: More Than Just Taking Meetings

The job description involves managing the fund. In practice, it means juggling half a dozen roles, often in the same day.

Fund Creation and Structure

Before a single dollar is invested, GPs dive into legal documents. They negotiate the fund’s terms—management fees, carried interest, and key-person clauses. They draft the limited partnership agreement (LPA), which dictates everything from investment strategy to LP reporting requirements. This isn’t glamorous work, but it’s critical. A poorly drafted LPA can lead to disputes with LPs, regulatory headaches, or even lawsuits.

Deal Flow and Investment Decisions

GPs are the final gatekeepers for investments, but they don’t work alone. Junior team members source deals, conduct due diligence, and present opportunities. The GP’s job is to pressure-test the thesis: Is this founder credible? Does the market timing make sense? Can this company realistically return the fund? They negotiate terms—valuation, board seats, protective provisions—and often take a board seat themselves.

This is where the “hands-on” part kicks in. Unlike venture partners, who might drop by for quarterly updates, GPs are often deeply involved in strategic decisions. They help hire executives, pivot business models, and raise follow-on funding. GPs at top firms often spend significant time embedded with portfolio companies during crises.

Fund Operations and LP Management

GPs don’t just invest. They manage the fund’s operations. That includes:

• Cash flow management: Ensuring the fund has enough capital to deploy and meet commitments.
• LP reporting: Providing quarterly updates on portfolio performance, fund health, and material risks.
• Compliance: Navigating regulatory requirements—SEC filings in the U.S., AIFMD in Europe.
• Fundraising: Raising the next fund, typically 18–24 months after the current one closes.

This last part—fundraising—is where GPs earn their reputation. Institutional LPs—pension funds, endowments—don’t just hand over capital. They demand proof of past performance, a clear investment thesis, and alignment of interests. A GP who can’t raise the next fund is a GP who’s out of a job.

---

The Power Dynamic: GPs vs. Everyone Else

The GP role doesn’t exist in a vacuum. It’s part of a hierarchy, and the dynamics within a VC firm can be as fraught as those between the firm and its portfolio companies.

Venture Partners: The Advisors Without Skin in the Game

Venture partners are the “strategic advisors” of VC. They might have a track record—ex-founders, ex-operators—or deep expertise in a sector like AI or biotech. But they don’t have voting rights on investments. They don’t carry liability. And they don’t always have a formal role in the firm’s operations.

This creates tension. A venture partner might bring in a deal, only to see a GP take credit. Or they might push for an investment, only to be overruled without explanation. The lack of accountability cuts both ways: venture partners can offer valuable insights, but they’re also expendable. If they don’t deliver, the firm can quietly move on.

Junior Team Members: The Grinders Without Credit

The most contentious dynamic in VC is between GPs and the junior team members who do the legwork. Associates and principals source deals, conduct due diligence, and build financial models—but they rarely get credit for the investments that succeed.

Some industry observers have been vocal about this. *, he writes:

This isn’t just a morale issue. It’s structural. GPs control the narrative with LPs, the media, and the broader ecosystem. Junior team members are left to prove themselves elsewhere if they want to advance. The result? High turnover at the associate and principal levels, as ambitious investors jump to other firms or start their own funds.

---

Raising Capital: The GP’s Real Job

At the end of the day, a GP’s most important job isn’t picking winners. It’s convincing LPs to trust them with their money. And the LPs who matter most aren’t wealthy individuals or family offices. They’re institutional investors: pension funds (CalPERS, CPP Investments), insurers (Prudential, Allianz), endowments (Harvard, Yale), and sovereign wealth funds (Singapore’s Temasek, Norway’s NBIM).

These LPs don’t just write checks. They demand:

• Transparency: Detailed reporting on fund performance, fees, and risks.
• Alignment: Management fees that don’t incentivize reckless behavior.
• Co-investment rights: The ability to invest directly in portfolio companies alongside the fund.
• ESG mandates: Proof that the fund isn’t investing in fossil fuels or controversial tech.

GPs must balance these demands with their own investment strategy. A pension fund might want steady returns, but VC is inherently risky. An endowment might push for ESG compliance, but the best deals might not fit the criteria. The tension is constant: GPs need LP capital to deploy, but they also need the freedom to take bets LPs might not fully understand.

---

How Do You Become a GP? (Spoiler: It’s Hard)

There’s no single path to becoming a GP, but two tracks dominate.

The Founder Track

Many GPs are ex-founders who’ve built and sold companies. Their value isn’t just in their capital—it’s in their network, operational experience, and credibility with other founders. Examples:

• Marc Andreessen (Netscape → a16z)
• Ben Horowitz (Opsware → a16z)
• Peter Thiel (PayPal → Founders Fund)

These GPs often start their own firms, leveraging their track record to attract LPs. The advantage? They can raise capital quickly. The downside? They’re unproven as investors. Founding a company is hard. Picking winners is harder.

The Senior Firm Track

The more common path is rising through the ranks at an established firm. Associates become principals, principals become partners, and—if they’re lucky—partners become GPs. This path is slower, more political, and far less certain.

The catch? GP roles are rare. Most VCs never reach this level. The industry is top-heavy: a few prominent firms control a disproportionate share of capital. Even at smaller firms, the GP title is often reserved for the founding partners. Everyone else is a “partner” or “principal”—titles that sound impressive but don’t carry the same authority or liability.

---

The Criticism: GPs and the Deal Attribution Problem

The most persistent criticism of GPs isn’t about their investment decisions. It’s about who gets credit for them. As Jason Lemkin puts it:

“The GP didn’t source the deal.

This isn’t just about ego. It’s about incentives. If junior team members know they won’t get credit for deals they source, why should they go the extra mile? Why should they stick around if they’re doing the work but not reaping the rewards?

Some firms have tried to address this. Some firms have programs that reward individuals who bring in deals. Some firms offer profit-sharing arrangements to junior team members. But these are exceptions. The default is still: the GP’s name goes on the deal, and the GP’s bank account gets the carry.

---

GPs in the Broader Ecosystem: Private Equity vs. Venture Capital

The GP role isn’t unique to VC. Private equity funds also have GPs, and the legal and operational responsibilities are nearly identical. Both:

• Carry unlimited liability.
• Raise capital from institutional LPs.
• Deploy that capital into companies.
• Take board seats and influence strategy.

The key difference is the stage of the companies they invest in. VC GPs target early-stage startups—pre-revenue, pre-profit, often pre-product. PE GPs target mature companies—established revenue, predictable cash flows, and a clear path to exit.

This difference shapes everything:

• Risk profile: VC is higher risk, higher reward. PE is lower risk, lower reward—but still lucrative.
• Time horizon: VC funds typically have 10-year lives. PE funds often hold companies for 3–7 years.
• Operational involvement: VC GPs are more hands-on with product and hiring. PE GPs focus on financial engineering, cost-cutting, and bolt-on acquisitions.

But the legal structure is the same. Whether investing in a Series A startup or a leveraged buyout of a manufacturing company, the GP is the one on the hook.

---

The Future of the GP Role: Will the Model Hold?

The traditional GP model is under pressure. LPs demand more transparency, more alignment, and more co-investment rights. Founders push back against terms they see as unfair—liquidation preferences, board control. Junior team members are increasingly vocal about the lack of credit and career progression.

Some firms are experimenting with new structures:

• GP committees: Distributing decision-making authority among a group of partners, rather than concentrating it in a single GP.
• Flat hierarchies: Firms like First Round Capital have eschewed traditional titles, opting for a more egalitarian approach.
• Evergreen funds: Instead of raising discrete funds every few years, some firms adopt open-ended structures—Berkshire Hathaway is the extreme example.

But these are outliers. Most VC funds still operate under the traditional GP-LP model. The question isn’t whether the GP role will change. It’s whether the changes will come from within the industry or be forced by external pressures. Will LPs demand more transparency? Will founders reject terms that favor GPs over them? Will junior team members unionize?

The GP role isn’t going away. It’s too deeply embedded in the legal and financial structure of venture capital. But the power dynamics, the incentives, and the expectations are all in flux. The next decade will determine whether GPs remain the undisputed kings of VC—or whether the model evolves into something more collaborative, more transparent, and less hierarchical. The only certainty? The tension between control and credit, between risk and reward, isn’t going anywhere.

---